Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmoplantar Pustulosis”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Post-approval studies (Phase 4)Ended earlyNCT05710185
What this trial is testing

Deucravacitinib for the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Brigham and Women's Hospital 3
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Large-scale testing (Phase 3)Study completedNCT03022045
What this trial is testing

Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Psoriasis
AbbVie 18
Not applicableStudy completedNCT05670821
What this trial is testing

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03886246
What this trial is testing

Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 131
Large-scale testing (Phase 3)Active Not RecruitingNCT06323356
What this trial is testing

TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Takeda 18
Large-scale testing (Phase 3)Study completedNCT05239039
What this trial is testing

An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 39
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT04061252
What this trial is testing

KHK4827 in Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Kyowa Kirin Co., Ltd. 126
Not applicableLooking for participantsNCT07270003
What this trial is testing

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Xijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04399837
What this trial is testing

Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 123
Large-scale testing (Phase 3)Looking for participantsNCT06477536
What this trial is testing

Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT00301002
What this trial is testing

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

Who this might be right for
PsoriasisPalmoplantaris PustulosisPustular Psoriasis of Palms and Soles+2 more
The Guenther Dermatology Research Centre 15
Not applicableNot Yet RecruitingNCT07448428
What this trial is testing

Generalized Pustular Psoriasis Registry in Costa Rica

Who this might be right for
Generalized Pustular PsoriasisGeneralized Pustular Psoriasis (GPP)
Caja Costarricense de Seguro Social 50
Early research (Phase 1)Study completedNCT05512598
What this trial is testing

HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis
Shanghai Huaota Biopharmaceutical Co., Ltd. 9
Post-approval studies (Phase 4)Study completedNCT03942042
What this trial is testing

Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Eli Lilly and Company 12
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Load More Results